Literature DB >> 2244640

Outcome of patients with chronic affective disorder: a five-year follow-up.

W Coryell1, J Endicott, M Keller.   

Abstract

Patients with major depression, mania, or schizo-affective disorder that had been present without remission for 2 years or more at intake (N = 129) were followed prospectively for 5 years, as were 580 patients who had been ill for shorter periods at intake. Despite very substantial durations of episode, three-quarters of the chronic patients recovered, although recovery occurred much later in the follow-up period than it did among the nonchronic patients. Factors associated with recovery were less severe illness at intake, lack of psychotic features, good friendship patterns in adolescence, and, most important, a relatively high maximum level of functioning in the 5 years preceding intake.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2244640     DOI: 10.1176/ajp.147.12.1627

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  10 in total

1.  Age of onset and progression of hoarding symptoms in older adults with hoarding disorder.

Authors:  Mary E Dozier; Ben Porter; Catherine R Ayers
Journal:  Aging Ment Health       Date:  2015-04-24       Impact factor: 3.658

2.  The lifetime cost of bipolar disorder in the US: an estimate for new cases in 1998.

Authors:  C E Begley; J F Annegers; A C Swann; C Lewis; S Coan; W B Schnapp; L Bryant-Comstock
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 3.  Prevalence and outcome of partial remission in depression.

Authors:  Richard Tranter; Claire O'Donovan; Praful Chandarana; Sidney Kennedy
Journal:  J Psychiatry Neurosci       Date:  2002-07       Impact factor: 6.186

4.  Levomilnacipran Extended-Release Treatment in Patients With Major Depressive Disorder: Improvements in Functional Impairment Categories.

Authors:  Andrew J Cutler; Carl P Gommoll; Changzheng Chen; William M Greenberg; Adam Ruth
Journal:  Prim Care Companion CNS Disord       Date:  2015-06-11

5.  Outcome of single manic episode in bipolar I disorder: a six-month follow-up after hospitalization.

Authors:  Majid Barekatain; Reihaneh Khodadadi; Mohammad Reza Maracy
Journal:  J Res Med Sci       Date:  2011-01       Impact factor: 1.852

6.  Time to relapse and remission of bipolar disorder: findings from a 1-year prospective study in Thailand.

Authors:  Thawatchai Leelahanaj; Ronnachai Kongsakon; Somrak Choovanichvong; Sookjaroen Tangwongchai; Suchat Paholpak; Thoranin Kongsuk; Manit Srisurapanont
Journal:  Neuropsychiatr Dis Treat       Date:  2013-08-22       Impact factor: 2.570

Review 7.  Depression and Mania in Bipolar Disorder.

Authors:  Leonardo Tondo; Gustavo H Vázquez; Ross J Baldessarini
Journal:  Curr Neuropharmacol       Date:  2017-04       Impact factor: 7.363

8.  Psychotic symptoms in bipolar disorder and their impact on the illness: A systematic review.

Authors:  Subho Chakrabarti; Navdeep Singh
Journal:  World J Psychiatry       Date:  2022-09-19

9.  Efficacy of levomilnacipran extended-release in improving functional impairment associated with major depressive disorder: pooled analyses of five double-blind, placebo-controlled trials.

Authors:  Angelo Sambunaris; Carl Gommoll; Changzheng Chen; William M Greenberg
Journal:  Int Clin Psychopharmacol       Date:  2014-07       Impact factor: 1.659

10.  Standardisation framework for the Maudsley staging method for treatment resistance in depression.

Authors:  Abebaw Fekadu; Jacek G Donocik; Anthony J Cleare
Journal:  BMC Psychiatry       Date:  2018-04-11       Impact factor: 3.630

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.